The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies
暂无分享,去创建一个
Christos J. Markopoulos | C. Markopoulos | F. Wärnberg | P. Christiansen | L. Bergkvist | Leif Bergkvist | M. Sund | Malin Sund | Fredrik Wärnberg | Staffan Eriksson | Andreas Karakatsanis | Peer Michael Christiansen | Lone Fischer | Christina Hedin | Lida Pistioli | Nils Ryegaard Rasmussen | Hjørdis Jørnsgård | Daniel Tegnelius | Kosmas Daskalakis | Lone Fischer | K. Daskalakis | A. Karakatsanis | S. Eriksson | C. Hedin | L. Pistioli | N. R. Rasmussen | H. Jørnsgård | D. Tegnelius
[1] J. Geraghty,et al. The Value of Isosulfan Blue Dye in Addition to Isotope Scanning in the Identification of the Sentinel Lymph Node in Breast Cancer Patients With a Positive Lymphoscintigraphy: A Randomized Controlled Trial (ISRCTN98849733). , 2015, Annals of surgery.
[2] J. M. Román-Santamaría,et al. Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: A comparative non-inferiority study. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[3] P. Rucci,et al. The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment , 2017, European journal of cancer care.
[4] Joost J. Pouw,et al. Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model , 2013, Breast Cancer Research and Treatment.
[5] G. Govaert,et al. Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[6] A. Derossis,et al. Is Breast Cancer the Same Disease in Asian and Western Countries? , 2010, World Journal of Surgery.
[7] N. Hauser,et al. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. , 2014, Breast.
[8] U. Chetty,et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.
[9] PhD Ebsq Frcs Vassilis Pitsinis MD,et al. Comparison of Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-Stage Breast Cancer , 2017, Annals of Surgical Oncology.
[10] Q. Pankhurst,et al. Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial , 2014, Annals of Surgical Oncology.
[11] A. Purushotham,et al. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. , 2014, The Lancet. Oncology.
[12] A. Tutt,et al. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer , 2012, Annals of Surgical Oncology.
[13] E. Rutgers,et al. UvA-DARE ( Digital Academic Repository ) Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS , 2010 .
[14] PhD Kazuyoshi Motomura MD,et al. SPIO-Enhanced Magnetic Resonance Imaging for the Detection of Metastases in Sentinel Nodes Localized by Computed Tomography Lymphography in Patients with Breast Cancer , 2011, Annals of Surgical Oncology.
[15] K. Hunt,et al. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis , 2016, Annals of Surgical Oncology.
[16] Q. Pankhurst,et al. Optimising magnetic sentinel lymph node biopsy in an in vivo porcine model. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[17] K. Slim,et al. Methodological index for non‐randomized studies (MINORS): development and validation of a new instrument , 2003, ANZ journal of surgery.
[18] V. Speirs,et al. Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[19] I. Rubio,et al. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[20] M. Carr,et al. Sentinel lymph node biopsy in early breast cancer surgery--working with the risks of vital blue dye to reap the benefits. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[21] F. Guillemin,et al. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial , 2016, Journal of surgical oncology.
[22] M. Somerfield,et al. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] D. Axelrod,et al. Patterns of Axillary Surgical Care for Breast Cancer in the Era of Sentinel Lymph Node Biopsy , 2009, Annals of Surgical Oncology.
[24] N. Sata,et al. Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study , 2014, Breast Cancer.
[25] Kei Aoyama,et al. Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green , 2011, World journal of surgical oncology.
[26] P. Dionigi,et al. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer , 2006, Expert review of anticancer therapy.
[27] C. Teo,et al. Blue dye is sufficient for sentinel lymph node biopsy in breast cancer , 2014, The British journal of surgery.
[28] Moriaki Kusakabe,et al. Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer , 2013, Breast Cancer.
[29] Joost J. Pouw,et al. Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol. , 2015, The British journal of radiology.
[30] S. Singletary,et al. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] A. C. Brown,et al. Allergic reactions to isosulfan blue during sentinel node biopsy--a common event. , 2001, Surgery.
[32] J. Olliver,et al. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus , 2003, The Lancet.
[33] Joost J. Pouw,et al. Comparison of three magnetic nanoparticle tracers for sentinel lymph node biopsy in an in vivo porcine model , 2015, International journal of nanomedicine.